Sorry, you need to enable JavaScript to visit this website.
Search

Search

Filter
41 - 50 of 52 results

Results for

How to Evaluate the Quality and Cost of Cancer Care? Teamwork

How to Evaluate the Quality and Cost of Cancer Care? Teamwork

Blog
D. Matthew Eby

D. Matthew Eby

Public Health Client Account Senior Lead
Matthew Eby has over 20 years of leadership experience in supporting life science research and consulting for military, federal public health, and international agencies. His diverse career spans basic and applied research on environmental bioremediation, designing nanomaterials to combat antimicrobial resistance, and protecting our nation against bioterrorism. He also led federal and international agencies in modernizing public health systems and pandemic response efforts. Clients have included the Air Force, Navy, Army, Defense Advanced Research Projects Agency, Centers for Disease Control and Prevention (CDC), Food and Drug Administration, National Institutes of Health, and United Arab Emirates. He  has authored more than 20 peer-reviewed publications with 1000+ citations. He also is an active supporter of local community initiatives that tackle affordable housing, food insecurity, and systemic poverty.
Brooke Abrams

Brooke Abrams

Client Solutions Architect
Brooke Abrams is a trained political scientist and researcher. With over 11 years of experience, she specializes in applied housing and health, bringing expertise in managing and contributing to place-based, mixed-method, and community-centered solutions. Her work spans research, evaluation, and technical assistance (TA) projects across diverse policy domains, delivering innovative and tailored strategies to drive impactful change.As a Client Solutions Architect at Abt, Abrams plays a pivotal role in designing client-focused frameworks and solutions that emphasize rigorous, data-informed, multi-disciplinary, and population-tailored design. She specializes in community-specific, monitoring, evaluation, and technical assistance approaches to engage and work alongside persons with lived expertise.
Dereje Dengela

Dereje Dengela

Principal Associate, PMI Evolve Project, Ethiopia
Dereje Dengela is an epidemiologist and entomologist with more than 25 years of experience in planning, implementation, monitoring, and evaluation of malaria control programs. He has extensive managerial experience, having supervised as many as 94 professionals. He has held senior positions with the government of Ethiopia, worked on projects for the U.S. Agency for International Development (USAID), and served as a national malaria program officer in Ethiopia. He supported the Ministry of Health of Ethiopia in mobilization of financial resources from donors, particularly the Global Fund. Dengela has authored or co-authored more than 30 publications in peer-reviewed journals.
Geoff Scahill

Geoff Scahill

Vice President, Program Delivery - Abt Australia
Default image

Abt Celebrates APPAM’s 40 Years of Evidence and Action

Blog
Sanjoti Parekh, PhD

Sanjoti Parekh, Ph.D.

Head of Domestic Programs, Abt Australia
Dr. Josephat Shililu

Dr. Josephat Shililu

Chief of Party, PMI VectorLink Project, Uganda
Dr. Josephat Shililu is a senior project manager and entomologist with over 20 years’ experience managing malaria control programs and conducting malaria vectors’ research. He has extensive expertise in project planning and implementation and has contributed to successful and timely implementation of IRS projects in Uganda, Ethiopia, Rwanda, and Kenya. He has also contributed to Ministries of Health (MOH’s) capacity strengthening efforts in malaria research, environmental compliance procedures, logistics systems, and mobilization campaigns. Dr. Shililu has ensured sound financial management and timely completion of quality project technical and financial deliverables.
intersect icon

How Can We Eradicate Infectious Diseases Using Machine Learning?

Podcast
In this month’s episode, Abt experts Jill Berkowitz and Sung-Woo Cho discuss how machine learning can amplify our work combatting malaria—25 million people protected to date—by applying what we’ve learned to other infectious diseases.